FIELD: medicine, pediatrics, peptides, pharmacy.
SUBSTANCE: invention relates to a medicinal agent and a method for treatment of neurological diseases in children from nurse age to 7 years. Invention proposes applying heptapeptide semax of the formula: Met-Glu-His-Phe-Pro-Gly-Pro in children of youngest age and a pharmaceutical composition of the preparation containing as an active substance heptapeptide semax of the formula: Met-Glu-His-Phe-Pro-Gly-Pro in the dose 0.1 g/l, and purified water. This preparation is in first recommended for treatment of disorders in nervous system in children of youngest age. The preparation provides its effective applying in low doses by simple applying since it is used as nasal drops.
EFFECT: improved treatment method, valuable medicinal properties of composition.
2 cl, 6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT AND METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE | 2008 |
|
RU2384343C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC INSULT AND METHOD FOR THERAPY | 2002 |
|
RU2251429C2 |
| NOOTROPIC DRUG AND PHARMACEUTICAL NOOTROPIC COMPOSITION | 1994 |
|
RU2045958C1 |
| INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
| METHOD FOR TREATING THE CASES OF ISCHEMIC INSULT | 1997 |
|
RU2124365C1 |
| USE OF PEPTIDE OF FORMULA MET-GLU-HIS-PHE-PRO-GLY-PRO FOR TREATING ANOSMIA IN COVID-19 | 2023 |
|
RU2816583C1 |
| METHOD OF TREATING VEGETATIVE-VASCULAR DYSTONIA AND MEDICINAL PRODUCT | 2013 |
|
RU2577130C2 |
| USE OF PEPTIDE Met-Glu-His-Phe-Pro-Gly-Pro (Semax) FOR DYSBIOSIS CORRECTION IN CHRONIC IMMOBILIZATION STRESS | 2019 |
|
RU2709527C1 |
| PHARMACEUTICAL COMPOSITION FOR GROWTH HORMONE DEFICIENCY THERAPY COMPRISING FUSED hGH PROTEIN | 2017 |
|
RU2748402C2 |
| TREATMENT OF PATHOLOGICAL BONE CONDITIONS IN PATIENTS WITH ACID SPHINGOMYELINASE DEFICIENCY | 2018 |
|
RU2795570C2 |
